The experimental induction of localised skeletal tuberculous lesions and their accessibility to streptomycin.
D000818:Animals; D001431:Bacteriological Techniques; D004195:Disease Models, Animal; D005269:Femur / Q000473:pathology / Q000601:surgery; D005781:Gelatin Sponge, Absorbable / Q000494:pharmacology; D006168:Guinea Pigs; D007273:Injections, Intramuscular; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009336:Necrosis; D013307:Streptomycin / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014386:Tuberculosis, Hepatic / Q000150:complications; D014388:Tuberculosis, Lymph Node / Q000150:complications; D014394:Tuberculosis, Osteoarticular / Q000150:complications / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D014397:Tuberculosis, Pulmonary / Q000150:complications; D014400:Tuberculosis, Splenic / Q000150:complications; D014947:Wounds and Injuries / Q000150:complications
D013307:Streptomycin